Background: In Caucasian patients with acute stroke or transient ischemic attack (TIA) due to symptomatic intracranial atherosclerotic stenoses (ICAS), only limited data on the recurrent stroke rate and its associated risk factors have been reported. In view of the increasing options for endovascular interventions, we sought to investigate the prevalence, risk for recurrent stroke and mortality in these patients. Methods: A total of 304 consecutive patients with acute ischemic stroke or TIA due to 50–99% ICAS were prospectively documented in 19 German stroke centers. In 201 patients (68.1% of the survivors), a central biannual telephone follow-up could assess recurrent stroke and mortality up to a median of 2 years after the index event. Results: An ischemic cerebrovascular event attributable to symptomatic ICAS was found in 2.24% of the consecutively admitted patients. The overall cumulative recurrent stroke rate after admission was 17.9% (95% CI = 13.4–23.5) for the first year and 23.3% (95% CI = 17.8–29.8) over 3 years. After correction for age and sex, only previous stroke (HR = 2.11, 95% CI = 1.14–3.91) and diabetes (HR = 2.41, 95% CI = 1.33–4.37) were significantly associated with recurrent stroke. Conclusion: Although the prevalence of this etiology seems very low in patients admitted to German stroke centers, we found a high risk of recurrent stroke in patients with symptomatic ICAS. Whether endovascular interventions can reduce this high risk needs to be determined in a randomized trial.

Keywords:
Cerebral ischemia, Stroke, Transient ischemic attack, Intracranial stenosis, prevalence, prognosis, Atherosclerosis
1.
Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR: Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990;40:1541–1545.
2.
Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R: Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50:812–813.
3.
Huang YN, Gao S, Li SW, Huang Y, Li JF, Wong KS, Kay R: Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997;48:524–525.
4.
Lee SJ, Cho SJ, Moon HS, Shon YM, Lee KH, Kim DI, Lee BB, Byun HS, Han SH, Chung CS: Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol 2003;60:1561–1564.
5.
DeSilva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC: South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke 2007;38:2592–2594.
6.
Gorelick PB, Wong KS, Bae HJ, Pandey DK: Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396–2399.
7.
Kim JS, Caplan LR, Wong LKS: Intracranial Atherosclerosis. West Sussex, Wiley-Blackwell, 2008.
8.
Weimar C, Goertler M, Harms L, Diener HC: Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol 2006;63:1287–1291.
9.
Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonzalez-Sanchez MA, Alvarez-Sabin J: Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001;32:2898–2904.
10.
Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan stroke study. Stroke 1995;26:14–20.
11.
Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974–1980.
12.
White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL: Ischemic stroke subtype incidence among Whites, Blacks, and Hispanics: the Northern Manhattan study. Circulation 2005;111:1327–1331.
13.
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–1316.
14.
Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F: Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006;66:1187–1191.
15.
Wong KS, Li H: Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003;34:2361–2366.
16.
Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–563.
17.
Man BL, Fu YP, Chan YY, Lam W, Hui CF, Leung WH, Wong KS: Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong. Cerebrovasc Dis 2009;28:112–118.
18.
Ley-Pozo J, Ringelstein EB: Noninvasive detection of occlusive disease of the carotid siphon and middle cerebral artery. Ann Neurol 1990;28:640–647.
19.
Baumgartner RW, Mattle HP, Schroth G: Assessment of ≧50% and <50% intracranial stenoses by transcranial color-coded duplex sonography. Stroke 1999;30:87–92.
20.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41.
21.
Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986;17:648–655.
22.
Navarro JC, Lao AY, Sharma VK, Tsivgoulis G, Alexandrov AV: The accuracy of transcranial Doppler in the diagnosis of middle cerebral artery stenosis. Cerebrovasc Dis 2007;23:325–330.
23.
Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M: The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007;68:2099–2106.
24.
Shin DH, Lee PH, Bang OY: Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol 2005;62:1232–1237.
25.
Kern R, Steinke W, Daffertshofer M, Prager R, Hennerici M: Stroke recurrences in patients with symptomatic versus asymptomatic middle cerebral artery disease. Neurology 2005;65:859–864.
26.
Arenillas JF, Molina CA, Chacon P, Rovira A, Montaner J, Coscojuela P, Sanchez E, Quintana M, Alvarez-Sabin J: High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004;63:27–32.
27.
Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, Hertzberg VS, Chaturvedi S, Levine SR, Stern BJ, Benesch CG, Jovin TG, Sila CA, Romano JG: Warfarin vs. aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006;67:1275–1278.
28.
Turan TN, Derdeyn CP, Fiorella D, Chimowitz MI: Treatment of atherosclerotic intracranial arterial stenosis. Stroke 2009;40:2257–2261.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.